국가: 영국
언어: 영어
출처: VMD (Veterinary Medicines Directorate)
Suxibuzone
Ecuphar Veterinaria S.L.U.
QM01AA90
Suxibuzone
Granules
POM-V - Prescription Only Medicine – Veterinarian
Horses
Anti Inflammatory NSAID
Authorized
2001-08-02
Revised: March 2022 AN: 02928/2021 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Danilon Equidos 1.5 g Granules for top dressing 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 10 g sachet contains ACTIVE SUBSTANCE G Suxibuzone (microencapsulated) 1.5 EXCIPIENT(S): Quinoline yellow (E 104) 0.0025 For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Granules for top dressing use. Yellow and odourless granules. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Equines. 4.2 INDICATIONS FOR USE Treatment of pain and inflammation associated with musculo-skeletal conditions in the horse _eg_ osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation. 4.3 CONTRA-INDICATIONS Do not administer to animals with renal, hepatic or cardiac disorders; where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product. Avoid use in dehydrated, hypovolemic or hypotensive animals as there is an increased risk of renal failure. Revised: March 2022 AN: 02928/2021 Page 2 of 6 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not administer to horses prior to taking part in a competition. During treatment of very young animals (less than 12 weeks) where development of their hepatic or renal function may be incomplete, or in aged animals which may have these functions impaired, as well as in ponies, additional risk may be involved. In these cases, doses should be accurately calculated and patients monitored closely. During treatment, do not restrict the consumption of water. Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there may be an increased risk of renal failure. NSAIDs can cause inhibition of phagocytosis and hence, in the treatment of inflammatory conditions associated with bacterial infections appropriate antimicrobial therapy should be instigated. 4.5 SPECIAL PRECAUTIONS FOR USE I. SPECIAL PRECAUTIONS FOR USE IN ANIMALS During treatment do not 전체 문서 읽기